Michèle Ollier
Michèle, MD and Business Master (Paris, France), joined the Index Ventures life science team as a Partner in 2006. From 2003, she was Director of Investment in Life Sciences at Edmond de Rothschild Investment Partners in Paris. During the previous 15 years she held various positions in companies such as Sanofi Pharma International, Bristol Myers Squibb France, Rhone Poulenc Rorer International/RPR Gencell as well as at Serono International, where she has been involved in the development, launch and marketing of a number of early to late stage drugs in various therapeutic areas as CNS, cardiovascular, oncology, reproductive medicine.
Michèle is a director of NormOxys Inc, Profibrix BV, Cyrenaic Inc, Aegerion Pharmaceuticals Inc as well as chairman of the board of directors of Sonkei Inc and of Funxional Therapeutics Ltd.